Continuous innovation, advanced technology, proven reliability
About us
Spectros Medical Devices Inc. makes advanced molecular sensing devices and software which shed light on tissue health and diseases related to vascular performance.
We are a private company focused on developing life changing consumer and medical devices based on in-vivo molecular optical technologies, including clinical devices for detection of ischemia, systemic perfusion, and vascular performance.
Our advanced T-Stat Tissue Oximeter utilizes innovative optical technology, with groundbreaking use of white LEDs that speed diagnosis, enable real-time therapies, reduce complications, and lower costs.
Our focus remains on improving patient outcomes, a dedication to manufacturing devices that are built on the most advanced and proven technology, while providing the highest level of service.
Spectros is a leader in noninvasive sensing and remote monitoring.
Our Mission
It is our mission to provide trusted medical devices that improve the lives of all people who require medical treatment. Our continued dedication to researching and understanding the world of medicine and the diseases that we face today is what drives our commitment to our patients.
Our team
Rob Pupelis,
CEO
Rob began his career in the medical device industry at Medical Alliance, Inc. in 1995. In an effort to learn every aspect of the business, he crossed over from sales into management and was awarded Regional Operations manager of the year in 2000. In 2002, he founded AAI working with multiple manufacturers as a top distributor with a focus on the Plastic & Reconstructive Surgery market. In 2017 he spearheaded efforts to purchase Spectros with a goal to take the T-Stat technology to the next level and expand Its clinical use both in the U.S. and around the world.
David Benaron, MD,
Founder
David Benaron is the founder of Spectros, along with multiple other biotechnology start-ups. He has an MD from Harvard, a Health Sciences degree from MIT, and attended as a physician in Intensive Care at Stanford University Medical School. He holds over 30 US and International patents in biomedical devices, methods, and technology. He also serves on the Board at companies outside of Spectros.
Elizabeth van Thillo,
VP Operations
Elizabeth has been with Spectros since 2007 and has had the opportunity to participate in many aspects of the companies growth. From overseeing marketing, moving the company from research to clinical sales, expanding markets across the US and EU. Most recently stepping into operations to source new manufacturers and manage the redevelopment of the core product, T-Stat. Her experience comes from working in Silicon Valley in marketing and sales at Netscape, Seascape and Shutterfly.
Bill Curnan, MBA, MS Physics
Regulatory Affairs
As head of regulatory affairs at several public & private companies (e.g., Ohmeda Pulse Oximeters, Aspen Labs, Dolphin Medical), Mr. Curnan has submitted more than 50 new applications for FDA, CE and other international approvals. He has successfully implemented FDA and ISO quality systems in US and overseas companies. In this role, he has managed all FDA & Competent Authorities communications and hosted numerous audits.
Our ability to understand and apply new technologies has earned us a reputation in the industry as a leader in the reliable application of new technologies to today’s most important medical challenges.